Published on Tuesday September 05, 2023
Smooth Drug Development August 2023 News Release
We are working on the following new projects:
- We were awarded with medical writing activities for bioequivalence trials with Triptorelin.
- Smooth received a project for a phase II-III trial in flu.
- We were awarded with a contract for a scientifical article for an international pharma company.
We are happy to reach the following milestones in our projects:
- We prepared CTA submission documents for the Edoxaban trial.
- 3 BE trials with Dolutegravir and Empagliflozin 10 mg and 25 mg were launched.
- 900 subjects are enrolled in the observational program of multivitamins in pregnant and childbearing women.